nach oben

Reactions Weekly

Erschienen in:

01.06.2019 | Case report

Ganciclovir

Acquired De novo ganciclovir resistance: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

McLean N, et al. De novo ganciclovir-resistant cytomegalovirus treated with foscarnet in a pediatric renal transplant recipient. Pediatric Transplantation 23 (Suppl. 1): 60 abstr. P 249, May 2019. Available from: URL: http://doi.org/10.1111/petr.13432 [abstract] - Canada

Titel: Ganciclovir
Acquired De novo ganciclovir resistance: case report
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63730-3

Ibrutinib

Case report

Amphotericin B liposomal

Case report

Ciclosporin/mycophenolate mofetil

Case report

Brimonidine

Case report

Docusate sodium/senna alexandrina abuse

Case report

Nivolumab

Case report

Springer Medizin

Ganciclovir

Acquired De novo ganciclovir resistance: case report

Excerpt

Weitere Artikel der Ausgabe 1/2019

Ibrutinib

Amphotericin B liposomal

Ciclosporin/mycophenolate mofetil

Brimonidine

Docusate sodium/senna alexandrina abuse

Nivolumab

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Ibrutinib

Amphotericin B liposomal

Ciclosporin/mycophenolate mofetil

Brimonidine

Docusate sodium/senna alexandrina abuse

Nivolumab